<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03987113</url>
  </required_header>
  <id_info>
    <org_study_id>2017022F</org_study_id>
    <nct_id>NCT03987113</nct_id>
  </id_info>
  <brief_title>Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning</brief_title>
  <acronym>Endoth-Exvivo</acronym>
  <official_title>Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale Rouen U1096</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study population will be patients with planned double-lung transplant, with preoperative
      ex-vivo reconditioning procedure.

      The ex-vivo procedure will be performed for lungs considered as limit to be directly
      implanted according to the national classification or in case of Maastrich 3 decision. They
      required a rehabilitation procedure like ex-vivo to determine their quality. Once the
      procedure initiated, the unused remaining liquid will be retrieved for the first gasometry
      usually performed. This will be the time T1 of sampling.

      The unused remaining liquid will be retrieved for the gasometry of end of procedure usually
      performed, before the graft cooling. This will be the time T2.

      The purge liquid of first lung at the declamping of the pulmonary artery will be retrieved at
      the time of unclamping (time T3 of sampling).

      The purge liquid of the second lung at the declamping of the pulmonary artery will be
      retrieved with the same procedure (time T4 of sampling).

      The samples will be analysed with ELISA technique. The endothelial dysfunction will be
      evaluated with plasma concentration of heparan sulphate, syndecan-1, endothelin-1 and i-NOS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 15, 2018</start_date>
  <completion_date type="Actual">October 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between time of cold ischemia and endothelial dysfunction</measure>
    <time_frame>24 hours</time_frame>
    <description>Plasma concentration in heparin sulphate, syndecan-1, endothelin-1 and i-NOS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between time of cold ischemia and systemic inflammation</measure>
    <time_frame>24 hours</time_frame>
    <description>Plasma concentration in IL-1β, IL-8, IL-10 and TNF-α</description>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Lung Transplant</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Plasma concentration analysis during and after ex-vivo pulmonary reconditioning</intervention_name>
    <description>The pulmonary endothelial dysfunction will be evaluated with plasma concentration of heparan sulphate, syndecan-1, endothelin-1 and i-NOS.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who requires a lung transplant, with ex-vivo reconditioning procedure. The
        objective is to create a plasma bank for all these patients with post analysis of sample.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Selection Criteria:

          -  patient aged &gt; 18 years old

          -  patient with healthcare insurance

          -  non-opposition of the patient

          -  patient with usual criteria for lung transplant and planned lung transplant after
             meeting of staff transplant

        Non Selection Criteria:

          -  participation refusal

          -  patient under tutorship or guardianship

          -  protected adult

        Inclusion Criteria:

          -  selected patient with Biomedecine Agency agreement for graft allocation off tour

        Exclusion Criteria:

          -  selected patient with Biomedicine Agency agreement for standard allocation graft
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morgan LE GUEN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anaesthesia department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 12, 2019</study_first_submitted>
  <study_first_submitted_qc>June 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2019</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

